Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-206 vs Esomeprazole PK/PD Study
NCT03980756Phase 1Completed
- Sponsor
- Addpharma, Inc.
- Start
- Jun 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of AD-206 in gastritis (4 arms), sponsored by Addpharma, Inc. Primary endpoints: Area under the plasma drug concentration-time curve at steady state and Change of integrated gastric acidity after 7 days of repeated administration. Started Jun 2019; status: completed.
02
Drugs
AD-206
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT03980756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03980756.